Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer.

Nature communications·2026
Same author

Quantifying the impact of social activities on SARS-CoV-2 transmission using Google mobility reports.

PLOS global public health·2026
Same author

Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential.

Communications medicine·2026
Same author

Joint probability framework for the development and validation of a prognostic model for the conditional outcome of quality of life: a retrospective study in historical European cohorts of survivors of head and neck cancer.

The Lancet. Digital health·2026
Same author

A novel diagnostic serum protein signature for pediatric inflammatory bowel disease.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients.

Acta oncologica (Stockholm, Sweden)·2025
Same journal

Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation.

Molecular oncology·2026
Same journal

In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

Molecular oncology·2026
Same journal

The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers.

Molecular oncology·2026
Same journal

EXPRESSION OF CONCERN: A Newly Identified 45-kDa JAK2 Variant with an Altered Kinase Domain Structure Represents a Novel Mode of JAK2 Kinase Inhibitor Resistance.

Molecular oncology·2026
Same journal

ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer.

Molecular oncology·2026
Same journal

Liquid biopsy-based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis.

Molecular oncology·2026
See all related articles

Related Experiment Video

Updated: Aug 16, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

840

Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Valeria Vitelli1, Thomas Fleischer2, Jørgen Ankill2

  • 1Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Norway.

Molecular Oncology
|December 23, 2022
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel Bayesian clustering method to identify robust cancer subgroups from whole-genome data. This approach reveals biologically meaningful pan-cancer clusters and novel subtypes with prognostic differences.

Keywords:
Bayes Mallows modelcluster analysispan-cancerrobust statisticssubgroup analysistranscriptomics

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

200
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Related Experiment Videos

Last Updated: Aug 16, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

840
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

200
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Analyzing large pan-cancer datasets for robust subgroup identification is challenging.
  • Existing methods may lack comprehensive uncertainty quantification and clear biological interpretability.

Purpose of the Study:

  • To develop and apply a novel rank-based Bayesian clustering method for pan-cancer data analysis.
  • To identify robust, biologically interpretable subgroups within diverse cancer types.

Main Methods:

  • Applied a novel rank-based Bayesian clustering approach to RNA-seq data from 12 Cancer Genome Atlas tumor types.
  • Integrated and quantified uncertainties from input data and the model.
  • Characterized clusters by top-ranked genomic features for biological interpretation.

Main Results:

  • Identified a robust clustering reflecting both tissue of origin and pan-cancer relationships.
  • Discovered three pan-squamous clusters (lung, head/neck, bladder) with distinct biological functions.
  • Uncovered two novel kidney cancer subtypes with differential prognoses and validated known breast cancer subtypes.

Conclusions:

  • The developed Bayesian clustering method effectively identifies robust and biologically meaningful clusters in pan-cancer samples.
  • The method provides probabilistic outputs for assessing cluster stability and reliable biological interpretation.
  • Findings highlight potential for discovering new cancer subtypes and understanding pan-cancer biology.